株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

放射性医薬品:技術および世界市場

Radiopharmaceuticals: Technologies and Global Markets

発行 BCC Research 商品コード 311757
出版日 ページ情報 英文 126 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

2016年12月31日まで 年末キャンペーン割引: BCC Research社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
放射性医薬品:技術および世界市場 Radiopharmaceuticals: Technologies and Global Markets
出版日: 2014年09月04日 ページ情報: 英文 126 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の放射性医薬品市場は2012年に38億米ドル、2013年には39億米ドル規模となりました。同市場は2014年には44億米ドルに拡大し、今後2019年までCAGR8%で拡大し、64億米ドル近くになると予測されています。

当レポートは、世界の放射性医薬品および関連技術市場の概要と、2014年、2019年の市場動向予測、様々な疾患への放射性医薬品の使われ方、法規制環境、および市場に参入する主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 概要

  • 用語
  • 歴史的背景
  • 放射性核種の源
  • 崩壊形式
  • 医療で一般的に用いられる放射性核種
  • 放射性医薬品の用途
  • 放射性医薬品の長所と短所

第4章 法規制の側面

  • 新薬承認と申請
  • 新薬申請
  • 安全性アラート
  • 有害事象報告
  • 薬剤不足
  • 放射性核種の小線源療法のための510K認可

第5章 新たな開発動向

  • パイプライン製品
  • 放射性医薬品における他の重要な新規開発

第6章 放射性医薬品の市場分析

  • タイプ別市場
  • タイプ別市場シェア
  • タイプ別治療用放射性医薬品
  • タイプ別治療法放射性医薬品市場シェア
  • 診断用放射性医薬品の地域別市場
  • 治療用放射性医薬品の地域別市場
  • 生産方法別放射性医薬品市場

第7章 バイオ医薬品の業界構造

  • 診断用放射性医薬品
    • PET診断
    • SPECT診断
    • その他
  • 治療用放射性医薬品
    • 市場リーダー
    • 市場シェア

第8章 特許分析

第9章 現況

  • 法規制の問題
  • 団塊世代
  • 生死に関わる疾患の発症率上昇
  • 意識向上
  • 競合
  • 技術的進歩
  • 業界の後退
  • 合併・買収・連携
  • 研究資金調達

第10章 企業プロファイル

第11章 略語解説

図表

目次
Product Code: PHM171A

REPORT HIGHLIGHTS

The global market for radiopharmaceuticals in 2012 was about $3.8 billion and $3.9 billion in 2013. The estimated market for the year 2014 is nearly $4.4 billion and this figure is forecast to expand through 2019 at a projected compound annual growth rate (CAGR) of 8%, approaching $6.4 billion.

This report provides:

  • An overview of the global market for radiopharmaceuticals and related technologies.
  • Analyses of global market trends, with data from 2012 and 2013, estimates for 2014, and projections of CAGRs through 2019.
  • Information on how radiopharmaceuticals are used to diagnose cancer, tumors, brain diseases, bone diseases, bone marrow diseases, colorectal disease, kidney diseases, liver diseases, lung diseases, and many others.
  • Details concerning the regulatory environment and the impacts of government on the market.
  • Profiles of leading companies in the industry.

SCOPE OF THE STUDY

The scope of this study encompasses radiopharmaceuticals in pharmaceutical markets. BCC Research analyzes each market and its applications, regulatory environment, technology, market projections and market shares. The report also covers the brachytherapy seeds. Technological issues include the latest trends and developments. The emerging market for radiopharmaceuticals includes countries like India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

ANALYSTS' CREDENTIALS

The study has been carried out by a team of professionals in biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has more than 15 years of industry experience. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY OBJECTIVES
  • REASONS FOR DOING THIS STUDY
  • CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
  • SCOPE OF THE STUDY
  • METHODOLOGY
  • INFORMATION SOURCES
  • ANALYSTS' CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - SUMMARY

  • SUMMARY TABLE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
  • SUMMARY FIGURE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 3 - OVERVIEW

  • TERMINOLOGY
    • RADIOPHARMACEUTICAL
    • RADIONUCLIDE
    • RADIOACTIVITY
    • RADIOACTIVE DECAY
    • NEGATRON
    • POSITRON
    • ELECTRON CAPTURE
    • ISOMERIC TRANSITION
    • TRANSMUTATION
    • HALF-LIFE
    • RADIATION
    • NUCLEAR MEDICINE
    • MYELOSUPPRESSION
    • LINEAR ENERGY TRANSFER (LET)
    • FISSION
  • HISTORICAL BACKGROUND
    • TABLE 1: DISCOVERY OF RADIOACTIVITY AND NUCLEAR MEDICINE
  • ORIGIN OF RADIONUCLIDES
    • PARTICLE ACCELERATOR-PRODUCED RADIONUCLIDES
      • TABLE 2: CYCLOTRON RADIONUCLIDE/RADIOISOTOPES
    • NUCLEAR REACTOR-PRODUCED RADIONUCLIDES
      • TABLE 3: NUCLEAR REACTOR RADIONUCLIDES/RADIOISOTOPES
    • RADIONUCLIDE GENERATORS
      • TABLE 4: RADIONUCLIDE GENERATORS
  • MODES OF DECAY
  • COMMONLY USED RADIONUCLIDES IN MEDICINE
    • TECHNETIUM-99M
    • IODINE-123
    • THALLIUM-201
    • GALLIUM-67
  • APPLICATIONS OF RADIOPHARMACEUTICALS
    • DIAGNOSTIC USE OF RADIOPHARMACEUTICALS
      • TABLE 5: EXAMPLES OF DIAGNOSTIC RADIOPHARMACEUTICALS
    • TYPES OF DIAGNOSTIC RADIOPHARMACEUTICALS
      • PET Radiopharmaceuticals
      • SPECT Radiopharmaceuticals
    • THERAPEUTIC RADIOPHARMACEUTICALS
      • TABLE 6: EXAMPLES OF THERAPEUTIC RADIOPHARMACEUTICALS
      • Alpha Emitters
        • TABLE 7: EXAMPLES OF ALPHA EMITTERS
        • TABLE 8: ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
      • Beta Emitters
        • TABLE 9: ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
      • Brachytherapy
        • TABLE 10: COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
      • TABLE 11: ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
  • ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
    • TABLE 12: ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS

CHAPTER 4 - REGULATORY ASPECTS

  • NEW DRUG APPROVALS AND APPLICATIONS
    • TABLE 13: NEW DRUG APPROVALS (FROM 2011- MARCH 2014)
  • NEW DRUG APPLICATIONS
    • TABLE 14: NEW DRUG APPLICATIONS (FROM 2010-MARCH 2014)
  • SAFETY ALERTS
    • TABLE 15: SAFETY ALERTS FOR RADIOPHARMACEUTICALS (FROM 2010-MARCH 2014)
  • ADVERSE EVENT REPORTING
    • TABLE 16: ADVERSE EVENT REPORTING (FROM 2010-MARCH 2014)
  • DRUG SHORTAGE
    • TABLE 17: RESOLVED DRUG SHORTAGE IN 2013
  • 510K APPROVALS FOR RADIONUCLIDE BRACHYTHERAPY SOURCE
    • TABLE 18: 510K APPROVALS (FROM 2010-MARCH 2014)

CHAPTER 5 - NEW DEVELOPMENTS

  • PIPELINE PRODUCTS
    • TABLE 19: PIPELINE PRODUCTS IN RADIOPHARMACEUTICALS
  • OTHER SIGNIFICANT NEW DEVELOPMENTS IN RADIOPHARMACEUTICALS

CHAPTER 6 - MARKET ANALYSIS OF RADIOPHARMACEUTICALS

  • MARKET BY TYPES OF RADIOPHARMACEUTICALS
    • GLOBAL RADIOPHARMACEUTICALS MARKET
      • TABLE 20: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, THROUGH 2019 ($ MILLIONS)
      • FIGURE 1: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, 2012-2019 ($ MILLIONS)
      • Market Share
        • TABLE 21: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
        • FIGURE 2: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
    • DIAGNOSTIC RADIOPHARMACEUTICALS MARKET BY TYPE OF DIAGNOSTIC TEST
      • Market Overview
      • Market Revenue
        • TABLE 22: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, THROUGH 2019 ($ MILLIONS)
        • FIGURE 3: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, 2012-2019 ($ MILLIONS)
      • PET Radiopharmaceuticals
        • PET Radiopharmaceuticals Market by Region
          • Market Overview
          • Market Revenue
            • TABLE 23: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
            • FIGURE 4: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
        • PET Radiopharmaceuticals Market by Type of Radionuclide
          • Market Overview
          • Market Revenue
            • TABLE 24: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
            • FIGURE 5: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, 2012-2019 ($ MILLIONS)
      • SPECT Radiopharmaceuticals
        • SPECT Radiopharmaceuticals Market by Region
          • Market Overview
          • Market Revenue
            • TABLE 25: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
            • FIGURE 6: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
        • SPECT Radiopharmaceuticals Market by Type of Isotope
          • Market Overview
          • Market Revenue
            • TABLE 26: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
            • FIGURE 7: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
      • Other Diagnostic Radiopharmaceuticals
        • Other Diagnostic Radiopharmaceuticals Market by Region
          • Market Overview
          • Market Revenue
            • TABLE 27: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
            • FIGURE 8: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
        • Other Diagnostic Radiopharmaceuticals Market By Type of Radionuclide
          • Market Overview
          • Market Revenue
            • TABLE 28: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
            • FIGURE 9: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE OF DIAGNOSTICS RADIOPHARMACEUTICAL BY TYPE
    • TABLE 29: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
    • FIGURE 10: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
  • THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE
    • Market Overview
    • Market Revenue
      • TABLE 30: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 11: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • Alpha Emitters
      • Alpha Emitters Market by Region
        • Market Overview
        • Market Revenue
          • TABLE 31: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 12: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
      • Alpha Emitters Market by Type of Radionuclide
        • Market Overview
        • Market Revenue
          • TABLE 32: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
          • FIGURE 13: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • Beta Emitters
      • Beta Emitters Market by Region
        • Market Overview
        • Market Revenue
          • TABLE 33: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 14: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
      • Beta Emitters by Type of Radionuclide
        • Market Overview
        • Market Revenue
          • TABLE 34: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
          • FIGURE 15: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • Brachytherapy Seeds
      • Brachytherapy Seeds Market by Region
        • Market Overview
        • Market Revenue
          • TABLE 35: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 16: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
      • Brachytherapy Seeds Market by Type of Radioisotope
        • Market Overview
        • Market Revenue
          • TABLE 36: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
          • FIGURE 17: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
  • MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICAL BY TYPE
    • TABLE 37: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
    • FIGURE 18: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
  • MARKETS BY REGION FOR DIAGNOSTIC RADIOPHARMACEUTICALS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 38: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 19: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 39: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
      • FIGURE 20: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
  • MARKETS BY REGION FOR THERAPEUTIC RADIOPHARMACEUTICALS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 40: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 21: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 41: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
      • FIGURE 22: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
  • RADIOPHARMACEUTICALS MARKET BY PRODUCTION METHOD
    • PARTICLE ACCELERATORS (CYCLOTRONS)
    • NUCLEAR REACTORS
    • RADIONUCLIDE GENERATORS
      • MARKET OVERVIEW
      • MARKET REVENUE
        • TABLE 42: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
        • FIGURE 23: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
      • MARKET SHARE
        • TABLE 43: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)
        • FIGURE 24: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)

CHAPTER 7 - INDUSTRY STRUCTURE FOR BIOPHARMACEUTICALS

  • DIAGNOSTIC RADIOPHARMACEUTICALS
    • PET DIAGNOSTIC RADIOPHARMACEUTICALS
      • Market Leaders
        • TABLE 44: GLOBAL MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013
      • Market Share
        • TABLE 45: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
        • FIGURE 25: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
    • SPECT DIAGNOSTIC RADIOPHARMACEUTICALS
      • Market Leaders
        • TABLE 46: GLOBAL MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013
      • Market Share
        • TABLE 47: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
        • FIGURE 26: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
    • OTHER DIAGNOSTIC RADIOPHARMACEUTICALS
      • Market Leaders
        • TABLE 48: GLOBAL MANUFACTURERS/ SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013
      • Market Share
        • TABLE 49: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
        • FIGURE 27: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
  • THERAPEUTIC RADIOPHARMACEUTICALS
    • MARKET LEADERS
      • TABLE 50: GLOBAL MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013
    • MARKET SHARE
      • TABLE 51: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)
      • FIGURE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)

CHAPTER 8 - PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 52: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
    • FIGURE 29: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
  • PATENTS BY TYPE/CATEGORY
    • TABLE 53: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
    • FIGURE 30: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
  • PATENTS BY COMPANY
    • TABLE 54: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
    • FIGURE 31: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
  • PATENTS BY COUNTRY
    • TABLE 55: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • FIGURE 32: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • TABLE 56: PATENT SHARES, BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
    • FIGURE 33: PATENT SHARES BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
  • PATENTS BY ASSIGNEE
    • TABLE 57: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014
    • FIGURE 34: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014

CHAPTER 9 - CURRENT SITUATION

  • REGULATORY ISSUES
  • BABY-BOOMER GENERATION
  • INCREASING INCIDENCE OF LIFE THREATENING DISEASES
  • RISING AWARENESS
  • COMPETITION
  • TECHNOLOGICAL ADVANCEMENTS
  • SETBACKS IN INDUSTRY
  • MERGERS, ACQUISITIONS AND COLLABORATIONS
  • FUNDING FOR RESEARCH

CHAPTER 10 - COMPANY PROFILES

  • ACTINIUM PHARMACEUTICALS INC.
  • ADVANCED MEDICAL ISOTOPE CORP.
  • ALSERES PHARMACEUTICALS INC.
  • AUSTRALIAN NUCLEAR ASSOCIATION AND TECHNOLOGY ORGANIZATION (ANSTO)
  • AVID RADIOPHARMACEUTICALS INC.
  • BARD MEDICAL
  • BAYER HEALTHCARE PHARMACEUTICALS
  • BOARD OF RADIATION AND ISOTOPE TECHNOLOGY (BRIT)
  • BRACCO DIAGNOSTICS INC.
  • CARDINAL HEALTH INC.
  • ELI LILLY AND COMPANY
  • ERIGAL LIMITED
  • FUJIFILM IR PHARMA CO. LTD.
  • GE HEALTHCARE (SUBSIDIARY OF GENERAL ELECTRIC COMPANY)
  • ISOTEX DIAGNOSTICS INC.
  • IBA MOLECULAR
  • ISORAY MEDICAL
  • JAZZ PHARMACEUTICALS
  • JUBILANT DRAXIMAGE INC.
  • LANTHEUS MEDICAL IMAGING INC.
  • MALLINCKRODT
  • NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM
  • NATIONAL INSTITUTE OF RADIOELEMENT (IRE)
  • NAVIDEA BIOPHARMACEUTICALS INC.
  • NORDION INC.
  • NTP RADIOISOTOPES (PTY) LTD.
  • PHARMALUCENSE INC.
  • PIRAMAL IMAGING
  • SIEMENS AG
  • TRIAD ISOTOPES INC.

CHAPTER 11 - ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 1: DISCOVERY OF RADIOACTIVITY AND NUCLEAR MEDICINE
    • TABLE 2: CYCLOTRON RADIONUCLIDE/RADIOISOTOPES
    • TABLE 3: NUCLEAR REACTOR RADIONUCLIDES/RADIOISOTOPES
    • TABLE 4: RADIONUCLIDE GENERATORS
    • TABLE 5: EXAMPLES OF DIAGNOSTIC RADIOPHARMACEUTICALS
    • TABLE 6: EXAMPLES OF THERAPEUTIC RADIOPHARMACEUTICALS
    • TABLE 7: EXAMPLES OF ALPHA EMITTERS
    • TABLE 8: ADVANTAGES AND DISADVANTAGES OF ALPHA EMITTERS
    • TABLE 9: ADVANTAGES AND DISADVANTAGES OF BETA EMITTERS
    • TABLE 10: COMMONLY USED RADIONUCLIDES (RADIATION SOURCES) FOR BRACHYTHERAPY
    • TABLE 11: ADVANTAGES AND DISADVANTAGES OF BRACHYTHERAPY
    • TABLE 12: ADVANTAGES AND DISADVANTAGES OF RADIOPHARMACEUTICALS
    • TABLE 13: NEW DRUG APPROVALS (FROM 2011- MARCH 2014)
    • TABLE 14: NEW DRUG APPLICATIONS (FROM 2010-MARCH 2014)
    • TABLE 15: SAFETY ALERTS FOR RADIOPHARMACEUTICALS (FROM 2010-MARCH 2014)
    • TABLE 16: ADVERSE EVENT REPORTING (FROM 2010-MARCH 2014)
    • TABLE 17: RESOLVED DRUG SHORTAGE IN 2013
    • TABLE 18: 510K APPROVALS (FROM 2010-MARCH 2014)
    • TABLE 19: PIPELINE PRODUCTS IN RADIOPHARMACEUTICALS
    • TABLE 20: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, THROUGH 2019 ($ MILLIONS)
    • TABLE 21: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
    • TABLE 22: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, THROUGH 2019 ($ MILLIONS)
    • TABLE 23: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 24: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 25: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 26: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 27: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 28: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 29: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
    • TABLE 30: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 31: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 32: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 33: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 34: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 35: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 36: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • TABLE 37: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
    • TABLE 38: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 39: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • TABLE 40: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 41: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • TABLE 42: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
    • TABLE 43: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)
    • TABLE 44: GLOBAL MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013
    • TABLE 45: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 46: GLOBAL MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013
    • TABLE 47: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 48: GLOBAL MANUFACTURERS/ SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013
    • TABLE 49: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 50: GLOBAL MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013
    • TABLE 51: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)
    • TABLE 52: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
    • TABLE 53: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
    • TABLE 54: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
    • TABLE 55: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • TABLE 56: PATENT SHARES, BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
    • TABLE 57: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL REVENUE OF RADIOPHARMACEUTICALS BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 1: MARKET FOR RADIOPHARMACEUTICALS BY CATEGORY, 2012-2019 ($ MILLIONS)
    • FIGURE 2: MARKET SHARE OF RADIOPHARMACEUTICALS BY CATEGORY IN 2013 (%)
    • FIGURE 3: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST, 2012-2019 ($ MILLIONS)
    • FIGURE 4: MARKET FOR PET RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 5: MARKET FOR PET RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, 2012-2019 ($ MILLIONS)
    • FIGURE 6: MARKET FOR SPECT RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 7: MARKET FOR SPECT RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 8: MARKET FOR OTHER DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 9: MARKET FOR OTHERS DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 10: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY TYPE OF DIAGNOSTIC TEST IN 2013 (%)
    • FIGURE 11: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 12: MARKET FOR ALPHA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 13: GLOBAL MARKET FOR ALPHA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 14: MARKET FOR BETA EMITTERS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 15: GLOBAL MARKET FOR BETA EMITTERS BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 16: MARKET FOR BRACHYTHERAPY SEEDS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 17: MARKET FOR BRACHYTHERAPY BY TYPE OF RADIONUCLIDE, THROUGH 2019 ($ MILLIONS)
    • FIGURE 18: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY TYPE IN 2013 (%)
    • FIGURE 19: MARKET FOR DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 20: MARKET SHARE OF DIAGNOSTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • FIGURE 21: MARKET FOR THERAPEUTIC RADIOPHARMACEUTICALS BY REGION, THROUGH 2019 ($ MILLIONS)
    • FIGURE 22: MARKET SHARE OF THERAPEUTIC RADIOPHARMACEUTICALS BY REGION IN 2013 (%)
    • FIGURE 23: MARKET FOR RADIOPHARMACEUTICALS BY PRODUCTION METHOD, THROUGH 2019 ($ MILLIONS)
    • FIGURE 24: MARKET SHARE OF RADIOPHARMACEUTICALS BY PRODUCTION METHOD, 2013 (%)
    • FIGURE 25: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF PET RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 26: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF SPECT RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 27: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF OTHER DIAGNOSTIC RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 28: MARKET SHARES OF MANUFACTURERS/SUPPLIERS OF THERAPEUTIC RADIOPHARMACEUTICALS, 2013 (%)
    • FIGURE 29: NUMBER OF SIGNIFICANT PATENTS BY YEAR, JANUARY 2010-APRIL 2014
    • FIGURE 30: PATENTS BY CATEGORY, JANUARY 2010-APRIL 2014
    • FIGURE 31: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY 2010-APRIL 2014
    • FIGURE 32: NUMBER OF U.S. PATENTS BY COUNTRY, JANUARY 2010-APRIL 2014
    • FIGURE 33: PATENT SHARES BY COUNTRY, JANUARY 2010-APRIL 2014 (%)
    • FIGURE 34: NUMBER OF PATENTS BY ASSIGNEE, JANUARY 2010-APRIL 2014
Back to Top